companydata.dkcompanydata.dk

10x Genomics Denmark ApS: Financial statements 2025

CVR: 40243224

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

10x Genomics Denmark ApS (CVR 40243224) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 3,442,436 and a net result of DKK 154,956 compared with DKK 183,445 the year before. That is an increase of 0.8% compared with the year before. Equity in the 2025 report amounted to DKK 973,740. The solvency ratio was 62.4%.

Gross Profit
DKK 3,442,436
Profit/Loss
DKK 154,956
Equity
DKK 973,740
Total Assets
DKK 1,560,346

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-3.4 mio.155 t.974 t.-
2024-3.4 mio.183 t.819 t.2
2023-2.1 mio.-587 t.635 t.2
2022-7.3 mio.2.8 mio.1.2 mio.5
2021-52.2 mio.39.8 mio.38.4 mio.2

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is 10x Genomics Denmark ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

James Sears Bryant joins 10x Genomics Denmark ApS as directorSep 16, 2025

As of September 16, 2025, James Sears Bryant is registered as director of 10x Genomics Denmark ApS.

Eric Stewart Whitaker steps down as director of 10x Genomics Denmark ApSSep 16, 2025

As of September 16, 2025, Eric Stewart Whitaker has stepped down as director of 10x Genomics Denmark ApS.

10x Genomics Denmark ApS: The 2024 annual report is outMay 22, 2025

10x Genomics Denmark ApS has published its annual report for 2024. Gross profit came to DKK 3,416,395, and the net result was DKK 183,445.

Auditor steps down at 10x Genomics Denmark ApSMay 15, 2025

As of May 15, 2025, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of 10x Genomics Denmark ApS.

About 10x Genomics Denmark ApS

10x Genomics Denmark ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Tetramer Shop ApS. The management consists of Adam Samuel Taich and James Sears Bryant. The company is owned by 10x Genomics, Inc.. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 3,442,436 and a net result of DKK 154,956 compared with DKK 183,445 the year before. Equity in the 2025 report amounted to DKK 973,740.

Source: annual report 2025, Danish Business Authority

Other financial years